Daniel J. Abdun-Nabi

Officials with Emergent BioSolutions, Inc., and Temasek Life Science Ventures recently announced a joint agreement to develop a vaccine to protect humans from strains of H5 influenza, or Avian flu.

H5N1

SAN DIEGO — Vical Inc. announced Feb. 24 the publication in the online edition of Vaccine1 detailed data from two Phase 1 trials of its Vaxfectin-adjuvanted DNA vaccines for H5N1 (avian-origin) influenza.

Social interaction between neighbors, work colleagues and other communities and social groups makes voluntary vaccination programs for epidemics such as H1N1 flu, SARS or avian flu a surprisingly effective method of disease control.

H5N1

QUEBEC CITY — Medicago Inc., a biotechnology company focused on developing vaccines based on proprietary manufacturing technologies and virus-like particles.

Avian flu

The Ministry of Health of Egypt has reported a new confirmed human case of avian influenza A (H5N1), the World Health Organization said Nov. 27.